These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29101263)

  • 21. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
    Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
    J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer.
    Park YE; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Han S; Jeon MY; Heo JY; Song K; Kim SU
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1221-1229. PubMed ID: 27859587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
    Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
    Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis B virus infection.
    Zhu MY; Zou X; Li Q; Yu DM; Yang ZT; Huang D; Chen J; Gong QM; Zhang DH; Zhang Y; Chen L; Chen PZ; Zhang XX
    J Viral Hepat; 2017 Jul; 24(7):589-598. PubMed ID: 28130852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Establishment and evaluation of noninvasive diagnostic models for liver fibrosis in patients with chronic hepatitis B].
    Yang Q; Liu DP; Li LP; Gu Y; Zhang MX; Liu Y; Yang K
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):15-20. PubMed ID: 28297773
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum hepatitis B surface antigen quantification as a useful assessment for significant fibrosis in hepatitis B e antigen-positive hepatitis B virus carriers.
    Xun YH; Zang GQ; Guo JC; Yu XL; Liu H; Xiang J; Liu J; Shi JP
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1746-55. PubMed ID: 23800140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gamma-glutamyl transpeptidase to platelet and gamma-glutamyl transpeptidase to lymphocyte ratio in a sample of Chinese Han population.
    Chen W; Hong D; Chen Z; Dai X; Cao J; Yu M; Li L
    BMC Gastroenterol; 2022 Oct; 22(1):442. PubMed ID: 36316645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis.
    Fung J; Lai CL; Fong DY; Yuen JC; Wong DK; Yuen MF
    Liver Int; 2008 Dec; 28(10):1408-16. PubMed ID: 18482268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
    Tu XL; Xiao YQ; Chen F
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relation between liver histopathology and GGT levels in viral hepatitis: more important in hepatitis B.
    Eminler AT; Irak K; Ayyildiz T; Keskin M; Kiyici M; Gurel S; Gulten M; Dolar E; Nak SG
    Turk J Gastroenterol; 2014 Aug; 25(4):411-5. PubMed ID: 25254524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum platelet-derived growth factor BB levels: a potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B.
    Zhou J; Deng Y; Yan L; Zhao H; Wang G;
    Int J Infect Dis; 2016 Aug; 49():94-9. PubMed ID: 27292607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B.
    Cai YJ; Dong JJ; Wang XD; Huang SS; Chen RC; Chen Y; Wang YQ; Song M; Chen YP; Li Z; Zhou MT; Shi KQ
    J Viral Hepat; 2017 Nov; 24(11):1005-1015. PubMed ID: 28419755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factors associated with liver stiffness in chronic liver disease].
    Lee DM; Moon EJ; Hwang JA; Lee MS; Cheong JY; Cho SW; Kim YB; Kim DJ; Hwang SG; Yang JM
    Korean J Hepatol; 2009 Dec; 15(4):464-73. PubMed ID: 20037265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
    Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
    BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.
    Forns X; Ampurdanès S; Llovet JM; Aponte J; Quintó L; Martínez-Bauer E; Bruguera M; Sánchez-Tapias JM; Rodés J
    Hepatology; 2002 Oct; 36(4 Pt 1):986-92. PubMed ID: 12297848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection.
    Varchetta S; Mele D; Lombardi A; Oliviero B; Mantovani S; Tinelli C; Spreafico M; Prati D; Ludovisi S; Ferraioli G; Filice C; Aghemo A; Lampertico P; Facchetti F; Bernuzzi F; Invernizzi P; Mondelli MU
    Gut; 2016 Dec; 65(12):1998-2006. PubMed ID: 26674359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum gamma-glutamyl transpeptidase activity in children with chronic hepatitis B].
    Lebensztejn DM; Skiba E; Sobaniec-Lotowska ME; Kaczmarski M
    Pol Merkur Lekarski; 2005 Mar; 18(105):271-4. PubMed ID: 15997630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.